 
MAINE STATE LEGISLATURE  
 
 
 
The following document is provided by the 
LAW AND LEGISLATIVE DIGITAL LIBRARY  
at the Maine State Law and Legislative Reference Library 
http://legislature.m aine.gov/lawlib 
 
 
 
 
 
 
 
 
 
 
Reproduced from electronic originals 
(may include minor formatting diffe rences from printed original) 
 
 
Printed on recycled paper131st MAINE LEGISLATURE
FIRST SPECIAL SESSION-2023
Legislative Document No. 1705
H.P. 1094 House of Representatives, April 18, 2023
An Act to Give Consumers Control over Sensitive Personal Data by 
Requiring Consumer Consent Prior to Collection of Data
Reference to the Committee on Criminal Justice and Public Safety suggested and ordered 
printed.
ROBERT B. HUNT
Clerk
Presented by Representative O'NEIL of Saco.
Cosponsored by Senator TIPPING of Penobscot, Senator HICKMAN of Kennebec and
Representatives: BOYER of Poland, LIBBY of Auburn, MALON of Biddeford, POIRIER of 
Skowhegan, RIELLY of Westbrook, Speaker TALBOT ROSS of Portland, Senators: 
BENNETT of Oxford, KEIM of Oxford.

Page 1 - 131LR1679(01)1Be it enacted by the People of the State of Maine as follows:
2Sec. 1.  10 MRSA c. 1057 is enacted to read:
3CHAPTER 1057
4PRIVACY OF BIOMETRIC IDENTIFIERS
5§9601.  Definitions
6 As used in this chapter, unless the context otherwise indicates, the following terms 
7 have the following meanings.
81.  Affirmative written consent.  "Affirmative written consent" means:
9 A.  A specific, unambiguous and informed written consent given by an individual who 
10 is not under duress or undue influence at the time the consent is given; or
11 B. In the context of employment, a release signed by an employee as a condition of 
12 employment.
132.  Biometric identifier.  "Biometric identifier" means information generated by 
14 measurements of an individual's unique biological characteristics, including a voiceprint or 
15 imagery of the iris, retina, fingerprint, face or hand, that can be used to identify that 
16 individual.  "Biometric identifier" does not include:
17 A.  A writing sample or written signature;
18 B.  A photograph or video, except for measurable biological characteristics that can be 
19 generated or captured from a photograph or video;
20 C.  A biological sample used for valid scientific testing or screening;
21 D.  Demographic information;
22 E.  A tattoo description or a physical description, such as height, weight, hair color or 
23 eye color;
24 F.  A donated organ, tissue or other body part, blood or serum stored on behalf of a 
25 recipient or potential recipient of a living or cadaveric transplant and obtained or stored 
26 by a federally designated organ procurement organization;
27 G.  Health care information, as defined in Title 22, section 1711-C, subsection 1, 
28 paragraph E, obtained for health care, as defined in Title 22, section 1711-C, subsection 
29 1, paragraph C; 
30 H.  An x-ray, computed tomography, magnetic resonance imaging, positron emission 
31 tomography, mammography or other image or film of the human anatomy used to 
32 diagnose or treat an illness or other medical condition or to further validate scientific 
33 testing or screening; or
34 I.  Information collected, used or disclosed for human subject research.
353.  Human subject research.  "Human subject research" means a systematic 
36 investigation, including research development, testing and evaluation, designed to develop 
37 or contribute to generalized knowledge and that is conducted in accordance with the federal 
Page 2 - 131LR1679(01)38 policy for the protection of human subjects under 45 Code of Federal Regulations, Part 46, 
39 the protection of human subjects under 21 Code of Federal Regulations, Parts 50 and 56 or 
40 security and privacy under 45 Code of Federal Regulations, Part 164, or other similar 
41 research ethics laws, or with the good clinical practice guidelines issued by the International 
42 Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use 
43 or successor organization.
74.  Personal information.  "Personal information" means information that identifies, 
8 relates to, describes, is reasonably capable of being associated with or could reasonably be 
9 linked, directly or indirectly, with a particular individual, household or electronic device.
105.  Private entity.  "Private entity" means an individual acting in a commercial 
11 capacity, partnership, corporation, limited liability company, association or other group, 
12 however organized.  "Private entity" does not include:
13 A.  A state or local government agency;
14 B.  A state court judge, justice or clerk of the court; or
15 C.  An entity acting as a processor for another entity.
166.  Processor.  "Processor" means a private entity that collects, processes, stores or 
17 otherwise uses biometric identifiers on behalf of another private entity.
18§9602.  Applicability
19 This chapter does not apply to:
201.  Admission or discovery of biometric identifier.  The admission or discovery of a 
21 biometric identifier in any action of any kind in any court or before any government 
22 tribunal, board or agency;
232.  Personal health information subject to HIPAA.  Personal health information 
24 subject to the federal Health Insurance Portability and Accountability Act of 1996, Public 
25 Law 104-191, and applicable regulations; 
263.  Personal information pursuant to Gramm-Leach-Bliley Act.  Personal 
27 information collected, processed, sold or disclosed pursuant to the federal Gramm-Leach-
28 Bliley Act, Public Law 106-102, and implementing regulations; or
294.  Facial surveillance.  Information governed by Title 25, chapter 701.
30§9603.  Biometric identifier policy requirements
311.  Development of policy.  Except as provided by subsection 3, a private entity in 
32 possession of biometric identifiers shall develop and make available to the public a written 
33 policy that establishes a retention schedule and guidelines for permanently destroying a 
34 biometric identifier of an individual on the earliest of:
35 A.  The date on which the initial purpose for obtaining the biometric identifier has been 
36 satisfied; 
37 B.  One year after the individual's last intentional interaction with the private entity in 
38 possession of the biometric identifier; and
39 C.  Thirty days after receiving a request to destroy the biometric identifier submitted 
40 by the individual or the individual's representative. A request received under this 
41 paragraph is not valid unless the private entity can verify using commercially 1
2
3
4
5
6
Page 3 - 131LR1679(01)42 reasonable methods that the individual who is the subject of the request is the individual 
43 whose biometric identifiers are in the possession of the private entity.
32.  Adherence to policy.  A private entity shall comply with the policy developed by 
4 the private entity under subsection 1, except for an action taken in response to a state or 
5 federal law or compulsory request or demand issued in an investigation conducted pursuant 
6 to state or federal law or taken to comply with a valid warrant, subpoena or other order 
7 issued by a court of competent jurisdiction. 
83.  Exception.  A private entity is not required to make available to the public a written 
9 policy that:
10 A.  Applies only to the employees of the private entity; and
11 B.  Is used solely within the private entity for the operation of the private entity.
12§9604.  Affirmative written consent
131. Release or user agreement.  For purposes of this chapter, the execution of a general 
14 release form or affirmation of a user agreement does not constitute affirmative written 
15 consent.  
162. Uses of affirmative written consent.  A private entity may only use the affirmative 
17 written consent regarding a biometric identifier of an employee of the private entity to 
18 permit access to a secure physical location or secure computer hardware or software and to 
19 record the beginning and end of the employee's work day and meal or rest breaks.  The 
20 private entity may not retain a biometric identifier related to access for the purpose of 
21 employee tracking. 
223. Electronic affirmative consent.  Affirmative written consent may be given by 
23 electronic means.  A user interface may not influence an individual toward giving 
24 affirmative written consent, and any default settings in a user interface must be designed to 
25 have as a default setting the option not to give affirmative written consent.
26§9605.  Storage, transmission and protection
271.  Standards.  A private entity or processor that collects or possesses a biometric 
28 identifier shall store, transmit and protect from disclosure that biometric identifier in a 
29 manner that is:
30 A.  Consistent with the reasonable standard of care used in the private entity's or 
31 processor's industry; and
32 B.  As protective or more protective than the manner in which the private entity or 
33 processor stores, transmits and protects from disclosure other confidential and sensitive 
34 information.
352.  Confidential and sensitive information.  For purposes of this section, "confidential 
36 and sensitive information" means personal information that can be used to identify an 
37 individual or an individual's account or property, including:
38 A.  Genetic testing information;
39 B.  A unique or personal identification number;
40 C.  An account number;
41 D.  A passcode; 1
2
Page 4 - 131LR1679(01)1 E.  A driver's license number; and
2 F.  A social security number.
3§9606.  Required disclosure
41.  Disclosure required.  On the request of an individual, a private entity that collects 
5 or possesses a biometric identifier shall disclose to that individual, free of charge, any 
6 biometric identifier associated with that individual and the information required by 
7 subsection 2. 
82.  Required information.  The information disclosed as required by subsection 1 must 
9 include all the relevant information for the period beginning 12 months before the biometric 
10 identifier was collected by or entered into the possession of the private entity and ending 
11 on the date of disclosure under this section, including:
12 A.  The type of biometric identifier;
13 B.  All personal information related to the biometric identifier;
14 C.  The types of sources from which the private entity obtained the biometric identifier 
15 and personal information linked to the biometric identifier;
16 D.  The use of the biometric identifier and personal information linked to the biometric 
17 identifier;
18 E.  The type of 3rd party with which the private entity has shared the biometric 
19 identifier; and
20 F.  The type of personal information linked to the biometric identifier that the private 
21 entity has disclosed to a 3rd party.
22§9607.  Prohibitions
231.  Collection, storage or dissemination without consent.  A private entity may not 
24 collect, store, purchase, receive through trade or otherwise obtain, use, disclose, transfer or 
25 otherwise disseminate an individual's biometric identifier unless the private entity first:
26 A.  Informs the individual in writing that a biometric identifier is being collected, 
27 stored, purchased, received through trade or otherwise obtained, used, disclosed, 
28 transferred or otherwise disseminated;
29 B.  Informs the individual in writing of the specific purpose and length of time for 
30 which a biometric identifier is being collected, stored, purchased, received through 
31 trade or otherwise obtained, used, disclosed, transferred or otherwise disseminated; and 
32 C.  Receives affirmative written consent from the individual.
33 This subsection does not apply to a disclosure of a biometric identifier if the disclosure 
34 completes a financial transaction requested or authorized by the individual, is required by 
35 state or federal law or is required pursuant to a valid warrant or subpoena issued by a court 
36 of competent jurisdiction.
372.  Sale, lease or trade prohibited.  A private entity that collects a biometric identifier 
38 may not:
39 A.  Sell, lease or trade that biometric identifier; or
Page 5 - 131LR1679(01)1 B.  Permit an entity to which the private entity transfers, shares or provides a biometric 
2 identifier to sell, lease or trade that biometric identifier.
33.  Discrimination.  A private entity may not:
4 A.  Condition a sale of goods or the provision of a service on the collection, use, 
5 disclosure, transfer, sale, retention or processing of a biometric identifier unless the use 
6 of a biometric identifier is strictly necessary to the sale of the goods or the provision of 
7 the service;
8 B.  Charge a different price or rate for goods or the provision of a service to a customer 
9 that does not provide affirmative written consent to providing a biometric identifier; or
10 C.  Provide a different quality of goods or a service to a customer that exercises a right 
11 described by this chapter.
124.  Processors.  A processor may not sell, lease or trade a biometric identifier.  A 
13 processor may not collect, store, process, use, disclose or conduct any action for profit or 
14 otherwise on or with biometric identifiers, except as authorized by a contract with a private 
15 entity that legally possesses the biometric identifiers.
16 A.  A contract between the processor and the private entity described by this subsection 
17 must expressly prohibit the processor from disclosing, retaining or using the biometric 
18 identifiers outside of the direct contractual relationship with the private entity.
19 B.  A private entity that contracts with a processor to process or store biometric 
20 identifiers may not allow the processor to collect, store, process, use, disclose or 
21 conduct any action for profit or otherwise on or with biometric identifiers, except for 
22 purposes for which the private entity received express affirmative written consent from 
23 the individual.
24§9608.  Remedies for violation
251.  Private right of action.  An individual alleging a violation of this chapter may bring 
26 a civil action against an offending private entity.  If the individual prevails in the action, 
27 the individual is entitled to:
28 A.  For a violation of this chapter:
29 (1)  As a result of negligence, actual damages or $1,000 per violation, whichever 
30 is greater; or
31 (2)  As a result of recklessness or intentional misconduct, actual damages or $5,000 
32 per violation, whichever is greater;
33 B.  Reasonable attorney's fees and court costs, including expert witness fees and other 
34 litigation expenses; and
35 C.  Other relief, including injunctive or equitable relief, as the court determines 
36 appropriate.
372.  Unfair trade practice.  In addition to subsection 1, any violation of this chapter 
38 constitutes prima facie evidence of a violation of the Maine Unfair Trade Practices Act.
393.  Enforcement by Attorney General.  The Attorney General may bring an action 
40 against a private entity for a violation of this chapter and seek any form of relief available 
41 to any other plaintiff, including the collection of damages as a civil penalty.
Page 6 - 131LR1679(01)1§9609.  Effective date
2 This chapter takes effect January 1, 2025.
3SUMMARY
4 This bill provides for an individual's privacy regarding the collection and use of 
5 biometric identifiers of the individual and personal information connected to the biometric 
6 identifiers.  The bill requires a written release from an individual before a private entity 
7 may obtain or use biometric identifiers and requires the private entity to establish a policy 
8 for retention and destruction of the biometric identifiers.  The bill provides for a private 
9 right of action for an aggrieved individual who has had biometric identifiers obtained or 
10 used in violation of the provisions related to biometric identifiers, as well as civil penalties 
11 and enforcement by the Attorney General.  The bill also provides that violations of 
12 provisions related to biometric identifiers constitute violations of the Maine Unfair Trade 
13 Practices Act.4
5
6
7
8
9
10
11
12
13
